Form 4 for LMAT LEMAITRE VASCULAR INC

Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-11 · accession 0001437749-21-028550 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-12-14	2021-12-11	LMAT	LeMaitre George W	COB, CEO, Dir, 10%	A - Grant	$48.60	+5,658	2.53M	+0.2%	+$275.0K
D	2021-12-14	2021-12-11	LMAT	LeMaitre George W	COB, CEO, Dir, 10%	A - Grant	$0.00	+30.9K	30.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-11	A	A	5,658	$48.60	2,526,852	D	—	—	(F1) Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
2	Derivative	Stock Option (Right to Buy)	2021-12-11	A	A	30,934	$0.00	30,934	D	$48.60 · 2021-12-11 to 2028-12-11	30,934 Common Stock	(F2) The exercise price of this option to the extent it is an incentive stock option (if at all) is $53.46 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $48.60 per share. (F3) This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. (F4) The expiration date of this option to the extent it is an incentive stock option (if at all) is 12/11/2026, and the expiration date of this option to the extent it is a nonqualified stock option is 12/11/2028.